Innovative Research Into Erectile Dysfunction In Diabetics Rewarded At ESSM Congress
The fourth annual ESSM Award of Excellence has been awarded to Professors Dr Carla Costa and Dr Pedro Vendeira for their ground-breaking research into erectile dysfunction in diabetics, during the 10th annual ESSM Congress taking place in Lisbon, Portugal.
New Patient Research Shows Importance Of Early Success In Treating Erectile Dysfunction
A UK study, made available at the 10th Congress of the European Society of Sexual Medicine in Lisbon, has warned healthcare professionals who treat erectile dysfunction (ED) of the importance of their first patient consultation.
Over-The-Counter Solution To Erectile Dysfunction
For couples worldwide, erectile dysfunction (ED) is one of the leading contributors to a man's inability to perform. As millions of men in America each year look for a solution, many seek alternative treatments to prescription medications and surgery that may have dangerous side effects.
New Study Shows LEVITRA Successfully Treats Erectile Dysfunction ED In Men With Dyslipidemia, Including High Cholesterol
Results of the first prospective trial specifically designed to evaluate erectile function in erectile dysfunction (ED) patients with dyslipidemia show that LEVITRA(R) (vardenafil HCl), used in treating ED, significantly improves the ability of men with ED and dyslipidemia to achieve and maintain an erection for successful sexual intercourse.
FDA Approves Cialis R tadalafil For Once Daily Use For The Treatment Of Erectile Dysfunction
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Cialis(R) (tadalafil)(1) for once daily use (2.5 mg and 5 mg), an oral medication taken once per day to treat erectile dysfunction (ED). When Cialis for once daily use is taken daily, men can attempt sexual activity at anytime between doses.
Slough Man Sentenced To Community Service For Peddling Counterfeit Medicines, UK
Mohammed Azim Dad (30) of 116 Chippenham Lane, Slough, SL1 5BA was sentenced to 250 hours community service on three counts under the Trade Marks Act 1994 relating to counterfeit erectile dysfunction medication, namely Viagra, Cialis and Levitra. Mr Dad appeared at Reading Crown Court following an investigation by the Medicines and Healthcare products Regulatory Agency (MHRA).
Cook Medical Launches Online Destination To Educate Physicians And Patients On A Leading Form Of Erectile Dysfunction
Cook Medical, announced the launch of www.MensHealthPD.
Daily Vardenafil For 6 Months Has No Detrimental Effects On Semen Characteristics Or Reproductive Hormones In Men With Normal Baseline Levels
UroToday.com - This a randomized, double-blind, placebo controlled, parallel group, multicenter study involving 200 men with or without erectile dysfunction. Men (25-64 years of age) did not have ejaculatory dysfunction. Subjects were randomized to daily treatment with vardenafil, sildenafil or placebo for 6 months.
Two Men Fined For Selling Erectile Dysfunction Drugs, UK
The Medicines and Healthcare products Regulatory Agency successfully prosecuted two men on 7 February 2008 at Bradford Magistrates Court for selling unlicensed medicines. David Tetley, (61) retired, and Stephen Evans, (49) unemployed, of 554 Leeds Road, Idle, Bradford, BD10 8JH, they pleaded guilty to the illegal sale and supply of Kamagra, Kamagra Oral Jelly and Loveagra.
High Levels Of The Molecule Adenosine Linked To Priapism
Priapism (prolonged penile erection in the absence of sexual interest) is common in male individuals with sickle cell disease (SCD), a blood disorder characterized by abnormally shaped red blood cells. Priapism is considered a medical emergency because it is associated with decreased blood flow to the erectile tissue, which can result in erectile tissue damage and, subsequently, erectile dysfunction and impotence.